No Photo Available

Last Update

2017-02-09T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Fred Eshelman?

Dr. Fred N. Eshelman

Board of Visitors

School of Pharmacy at UNC-CH

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

School of Pharmacy at UNC-CH

Background Information

Employment History

Chancellor

University of California , San Diego

Chancellor

North Carolina State University

Chancellor

University Professor Of Chemistry

Affiliations

Board Member
Valeant Pharmaceuticals International

Advisory Board Member
Auven Therapeutics

Board Member
Targanta Therapeutics Corp.

Board Member
Innocrin Pharmaceuticals Inc

Board Member
G1 Therapeutics , Inc.

Board Member
Neoantigenics Inc

Board Member
Medikidz Limited

Board Member
Cellective BioTherapy Inc

Board Member
AeroMD

Board Member
InvestCorrectly

Board Member
The Medicines Company

Board Member
Eyenovia , Inc.

Board Member
Meryx , Inc.

Board Member
Dignify Therapeutic , Inc.

Board of Governors
UNC School of Pharmacy

Steering Committee Member
Debt

Board Member
Carolina Business Coalition

Business Advisory Board Member
Princeton BioPharma Capital Partners LLC

Board Member
Association of Clinical Research Organizations

Advisory Board Member
Celtic Therapeutics

Board Member
Wilmington Chamber of Commerce

Member of the Pharmacy School's Board
Visitors

Advisory Board Member
Cellona Therapeutics

Board Member
Accelerator Corporation

Faculty Member
University of Cincinnati

Executive Committee
N.C. Medical Foundation

Board Member
Computer Solutions

Board Member
Aton Pharma , Inc.

Member
School of Ph..

Member, Board
Princeton Pharma Holdings LLC.

Board of Advisors Member
Catalytix Inc

Board Member
Oriel Therapeutics Inc.

Board Member
Spotlight Health Inc

Board Member
PRIMECYTE , Inc.

Board Member
PPGx

Member
Board of Visitors

Board of Trustees
Gov. Beverly Perdue

Board Member
Can.Board Listed/Public CompaniesThe Medicines Company

Chair, Board of Directors
SARCO , Inc.

Founder
Pharm

Chief Executive Officer
PPD Inc

Principal
Eshelman Ventures LLC

Executive Committee
The Medical Foundation of North Carolina Inc

Board of Trustees
University of North Carolina Wilmington

Senior Vice President, Development and Member of the Board of Directors
GlaxoSmithKline plc

Education

B.S.

Harvard Business School

B.S.

pharmacy

University of North Carolina at Chapel Hill. He

BSc

pharmacy

UNC-CH

BSc

pharmacy

University of North Carolina , Chapel Hill

Graduate of the Owner/President Management program

Harvard Business School

Ph.D.

University of North Carolina-Chapel Hill

Pharm.D.

The School of Pharmacy at UNC Chapel Hill

bachelor's degree

High Point University

bachelor's degree

pharmacy

Carolina

doctorate

pharmacy

University of Cincinnati

Web References (183 Total References)


Fredric N. Eshelman, ...

www.targanta.com [cached]

Fredric N. Eshelman, Pharm.D Non-Executive Chairman, Member of Audit Committee

Fredric N. Eshelman has been a director and chairman since August 2015. Dr. Eshelman has more than 35 years of strategic development, executive, operational and financial leadership experience in the pharmaceutical and healthcare industries. Dr. Eshelman was the founder of Pharmaceutical Product Development, Inc. (PPD) and founding chairman of Furiex Pharmaceuticals, Inc. In 2014, Dr. Eshelman founded Eshelman Ventures, LLC, an investment company focused on healthcare companies. From 2009 to 2014, Dr. Eshelman served as Chairman of the Board of Furiex. From 2009 to 2011, he served as Executive Chairman of PPD. He also served as Chief Executive Officer of PPD from 1990 to 2009 and as Vice Chairman of its Board of Directors from 1993 to 2009. Dr. Eshelman currently serves on the board of directors of AeroMD, Cellective Biotherapy, Inc., Dignify Therapeutic, Inc., Eyenovia, Inc., G1 Therapeutics, Inc., Innocrin Pharmaceuticals, Inc., Medikidz USA, Inc., Meryx, Inc. and Neoantigenics LLC and Valeant Pharmaceuticals International, Inc., and the advisory board of Auven Therapeutics.
Dr. Eshelman has served on the executive committee of the Medical Foundation of North Carolina, was on the Board of Trustees for UNC-W and in 2011 was appointed by the NC General Assembly to serve on the Board of Governors for the state's multi-campus university system as well as the NC Biotechnology Center. In addition, he chairs the board of visitors for the School of Pharmacy at UNC-CH. One of the top pharmacy programs in the United States, in May 2008 the school was named the UNC Eshelman School of Pharmacy in recognition of his many contributions to the school and the profession. Dr. Eshelman has received many awards including the Davie and Distinguished Service Awards from UNC and Outstanding Alumnus from both the UNC and University of Cincinnati schools of pharmacy, as well as the NC Entrepreneur Hall of Fame Award. He has received the doctor of pharmacy from the University of Cincinnati, completed a residency at Cincinnati General Hospital and a BS in pharmacy from UNC-CH. He is a graduate of the OPM program at Harvard Business School.


About Us | Eshelman Ventures LLC of Wilmington NC

www.eshelmanventures.com [cached]

Fred Eshelman is the founder of Eshelman Ventures LLC, an investment company primarily interested in private healthcare companies. He often serves on the boards of portfolio companies. Previously he founded and served as CEO and Executive Chairman of Pharmaceutical Product Development (PPDI, NASDAQ) prior to the sale of the company to private equity interests.

After PPD he served as Founding Chairman and largest shareholder of Furiex Pharmaceuticals (FURX, NASDAQ), a company which licensed and rapidly developed new medicines. Furiex was sold to Forest Labs/Actavis in July, 2014.
He is Chairman of The Medicines Company (MDCO, NASDAQ), and recently joined the board of Valeant Pharmaceuticals (VRX).
His career has also included positions as senior vice president (development) and board member of the former Glaxo, Inc., as well as various management positions with Beecham Laboratories and Boehringer Mannheim Pharmaceuticals.
Eshelman has served on the executive committee of the Medical Foundation of North Carolina, was on the Board of Trustees for UNC-W and in 2011 was appointed by the NC General Assembly to serve on the Board of Governors for the state's multi-campus university system as well as the NC Biotechnology Center. In addition, he chairs the board of visitors for the School of Pharmacy at UNC-CH, which was recently named the number one pharmacy school in the US. In May 2008 the school was named the UNC Eshelman School of Pharmacy in recognition of his many contributions to the school and the profession.
Eshelman has received many awards including the Davie and Distinguished Service Awards from UNC and Outstanding Alumnus from both the UNC and University of Cincinnati schools of pharmacy, as well as the NC Entrepreneur Hall of Fame Award and the NC business hall of fame. He received the doctor of pharmacy from the University of Cincinnati, completed a residency at Cincinnati General Hospital and a BS in pharmacy from UNC-CH. He completed the OPM program at Harvard Business School.


Fred Eshelman to Receive Life Science Leadership Award at the CED Life Science Conference 2016 | CED

cednc.org [cached]

Fred Eshelman to Receive Life Science Leadership Award at the CED Life Science Conference 2016 Life Sciences Press Releases Fred Eshelman to Receive Life Science Leadership Award at the CED Life Science Conference 2016

...
Fred Eshelman
Eshelman Joins Speaker Lineup of Fourteen World-Renowned Industry Leaders
DURHAM, NC - January 25, 2016 - The Council for Entrepreneurial Development (CED) today announced that Fred Eshelman will be presented with the Life Science Leadership Award at the 25th annual CED Life Science Conference (March 1-2, 2016 in Raleigh, NC). Eshelman will appear along with fourteen other confirmed speakers including global leaders in research, pharmaceuticals, biotechnology, medical device, and capital formation. Industry visionaries will converge with emerging entrepreneurs, investors, researchers, and professional service firms at the CED Life Science Conference, one of the leading life science gatherings in the nation that attracts over 1,000 participants each year.
As founder, CEO and Executive Chairman of PPD as well as founding Chairman of Furiex Pharmaceuticals, Fred Eshelman has played a pivotal role in the development of the North Carolina life science community. Eshelman has served on the executive committee of the Medical Foundation of North Carolina, was on the Board of Trustees for the University of North Carolina at Wilmington, and was appointed by the NC General Assembly in 2011 to serve on the Board of Governors for the state's multi-campus university system as well as the North Carolina Biotechnology Center. He also chairs the board of visitors for the School of Pharmacy at the University of North Carolina at Chapel Hill. One of the top pharmacy programs in the United States, the school was named the UNC Eshelman School of Pharmacy in May 2008 in recognition of his many contributions to the school and the profession. Additionally, Eshelman has demonstrated an incredible commitment to growing and sustaining this community as a generous donor and investor with Eshelman Ventures.
"I am honored to receive the 2016 Life Science Leadership Award at this celebrated annual gathering," said Eshelman. "I appreciate CED's work with many of the breakthrough companies in North Carolina and I am personally committed to the continued vibrancy of this region as a top life science cluster."
"Fred Eshelman's leadership in our life science community offers great inspiration to emerging innovators, especially as he continues his commitment to invest back into the entrepreneurial ecosystem of North Carolina.
...
Ernest Mario (Chairman of Chimerix., venture partner at Pappas Ventures), the 2015 recipient of the award, will introduce Eshelman at the conference and present him with the award.
...
Fred Eshelman will also speak at the conference, along with some of the most celebrated industry leaders:


The Medicines Company appoints ...

www.talent4boards.com [cached]

The Medicines Company appoints Fred Eshelman to its Board of Directors as Non-Executive Chairman The Medicines Company appoints Fred Eshelman to its Board of Directors as Non-Executive Chairman - Talent4Boards Talent4Boards info@talent4boards.com

...
HomeBoard - USA / Can.Board Listed/Public CompaniesThe Medicines Company appoints Fred Eshelman to its Board of Directors as Non-Executive Chairman
The Medicines Company appoints Fred Eshelman to its Board of Directors as Non-Executive Chairman
August 31, 2015 By Talent4Boards Team Comments are Off Board - USA / Can., Board Listed/Public Companies
- USA, NJ - The Medicines Company (NASDAQ:MDCO) today announced that its Board of Directors has named Dr. Fred Eshelman, founder of Eshelman Ventures LLC, an investment company focused on healthcare companies, as non-executive Chairman of The Medicines Company Board of Directors, effective immediately.
...
Dr. Eshelman has more than 35 years of strategic development, executive, operational and financial leadership experience in the pharmaceutical and healthcare industries. He is the founder and former Chief Executive Officer and Executive Chairman of Pharmaceutical Product Development, Inc. (PPD), a global contract pharmaceutical research organization providing drug discovery, development and lifecycle management services. Dr. Eshelman was also the founding chairman of Furiex Pharmaceuticals, Inc., a drug development company that collaborated with pharmaceutical and biotechnology companies to increase the value of their drug candidates by applying an accelerated approach to drug development.
...
"Fred brings a breadth of skills and experiences in our industry and has a proven track record of building and leading businesses that create significant value for customers and for shareholders. I am delighted to welcome Fred as Chairman and believe he will be an instrumental partner in designing strategy and driving growth."
"The Medicines Company has a range of very important assets that collectively represent diverse commercial opportunities, and I am honored to assume the role of Chairman at a point of unparalleled opportunity to grow the business and optimize the potential of the portfolio," said Dr. Eshelman.
...
Prior to Dr. Eshelman joining the Board, Eshelman Ventures, LLC, an entity wholly owned by Dr. Eshelman, purchased from The Medicines Company $30 million of the Company's common stock.
About Dr. Fred Eshelman
In addition to Dr. Eshelman's roles at Eshelman Ventures, LLC, PPD and Furiex Pharmaceuticals, he has also served as Senior Vice President, Development and member of the Board of Directors of the former Glaxo, Inc., as well as in various management positions with Beecham Laboratories and Boehringer Mannheim Pharmaceuticals.
Dr. Eshelman was appointed by the North Carolina General Assembly to serve on the Board of Governors for the state's multi-campus university system as well as the North Carolina Biotechnology Center. He also chairs the board of visitors for the School of Pharmacy at UNC-Chapel Hill, which was named the UNC Eshelman School of Pharmacy in recognition of his many contributions to the school and the profession. He has also served on the executive committee of the Medical Foundation of North Carolina and the Board of Trustees for UNC-Wilmington.
Dr. Eshelman received his Doctor of Pharmacy from the University of Cincinnati, and completed a residency at Cincinnati General Hospital. He received a Bachelor of Science in pharmacy from UNC-Chapel Hill and is also a graduate of the Owner/President Management program at Harvard Business School.


Fred ...

www.accpri.org [cached]

Fred Eshelman

...
Fred Eshelman
Fred Eshelman is the founder and chairman of Furiex Pharmaceuticals (NASDAQ: FURX). Previously he was the founder, Chairman, and CEO of Pharmaceutical Product Development (NASDAQ: PPDI) prior to its sale to private equity in 2011. PPD provided drug discovery and development services to biopharmaceutical and government organizations.
His career has also included positions as senior vice president of development and board member of the former Glaxo Inc., as well as various management positions with Beecham Laboratories and Boehringer Mannheim Pharmaceuticals.
Eshelman has served on the executive committee of the Medical Foundation of North Carolina and currently serves on a number of industry boards. He chairs the board of visitors for the School of Pharmacy at the University of North Carolina, his alma mater, and serves as an adjunct professor. One of the top pharmacy programs in the United States, in May 2008 the school was named the UNC Eshelman School of Pharmacy in recognition of his many contributions to the school and the pharmacy profession. Eshelman is also a member of the University of North Carolina System Board of Governors.
He has received many awards including the Davie and distinguished service awards from UNC, and outstanding alumnus from both the UNC and University of Cincinnati schools of pharmacy.
Eshelman received a doctor of pharmacy from the University of Cincinnati and a B.S. in pharmacy from the University of North Carolina at Chapel Hill. He is a graduate of the Owner/President Management Program at Harvard Business School.

Similar Profiles

Other People with this Name

Other people with the name Eshelman

Jeff Eshelman
Matheson Tri-Gas Inc

Peter Eshelman
Petroleum Traders Corporation

Renee Eshelman
CVM Law Group , LLP

Stacy Eshelman
Vedda Printing+

Patricia Eshelman
Hitchcock ISD

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory